Table 2 |
||||
|
Osteoblast gene expression in primary and fourth passage (P4) SF-derived osteoblast cultures from patients with juvenile idiopathic arthritis* |
||||
|
Primary cultures |
||||
|
|
||||
|
Gene |
oJIA (n = 12) |
pJIA (n = 4) |
||
|
|
||||
|
Day 14 |
Day 21 |
Day 14 |
Day 21 |
|
|
|
||||
|
Runx2 |
0.02 (0.01-0.07) |
0.05 (0.02-0.11) |
0.00 (0.00-0.01) |
0.02 (0.00-0.05) |
|
P (vs. pJIA) |
0.02 |
0.18 |
||
|
P (vs. day 21) |
0.20 |
0.34 |
||
|
OPG |
1.63 (0.39-5.65) |
13.99 (8.22-21.82) |
0.68 (0.40-1.48) |
1.52 (0.50-5.68) |
|
P (vs. pJIA) |
0.47 |
0.03 |
||
|
P (vs. day 21) |
0.001 |
0.49 |
||
|
RANKL |
0.08 (0.00-0.16) |
0.18 (0.04-0.50) |
0.12 (0.03-0.20) |
0.16 (0.06-0.20) |
|
P (vs. pJIA) |
0.54 |
0.90 |
||
|
P (vs. day 21) |
0.42 |
0.89 |
||
|
|
||||
|
P4 cultures |
||||
|
|
||||
|
oJIA (n = 7) |
pJIA (n = 4) |
|||
|
|
||||
|
Day 10 |
Day 14 |
Day 10 |
Day 14 |
|
|
|
||||
|
Runx2 |
0.04 (0.02-0.08) |
0.03 (0.02-0.05) |
0.02 (0.01-0.02) |
0.02 (0.01-0.03) |
|
P (vs. pJIA) |
0.02 |
0.32 |
||
|
P (vs. day14) |
0.46 |
0.20 |
||
|
OPG |
0.07 (0.04-0.08) |
0.12 (0.08-0.20) |
0.04 (0.01-0.06) |
0.04 (0.01-0.06) |
|
P (vs. pJIA) |
0.23 |
0.01 |
||
|
P (vs. day14) |
0.04 |
0.89 |
||
|
RANKL |
0.01 (0.01-0.03) |
0.01 (0.01-0.04) |
0.00 (0.00-0.00) |
0.01 (0.00-0.01) |
|
P (vs. pJIA) |
0.04 |
0.23 |
||
|
P (vs. day14) |
0.53 |
0.06 |
||
|
|
||||
|
*Values are median (interquartile range), statistical differences were calculated using the Mann-Whitney test. Patients were subdivided into the oligoarticular (oJIA) or polyarticular (pJIA) group according to the International League of Associations for Rheumatology (ILAR) criteria [3]. Day, day of osteoblast culture; OPG, osteoprotegerin gene; RANKL, receptor activator of NF-κB ligand gene; Runx2, runt-related transcription factor 2 gene. |
||||
|
Lazić et al. Arthritis Research & Therapy 2012 14:R139 doi:10.1186/ar3872 |
||||